These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23768850)

  • 1. [Safety and effectiveness of the influenza vaccine: new data, new challenges].
    Trilla A
    Med Clin (Barc); 2013 Jul; 141(2):67-9. PubMed ID: 23768850
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
    Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
    Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
    [No Abstract]   [Full Text] [Related]  

  • 3. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
    Myers CA; Faix DJ; Blair PJ
    Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews.
    Juvet LK; Robertson AH; Laake I; Mjaaland S; Trogstad L
    Front Immunol; 2021; 12():740048. PubMed ID: 34777351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
    Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
    N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data.
    Harris T; Wong K; Stanford L; Fediurek J; Crowcroft N; Deeks S
    Euro Surveill; 2014 Sep; 19(36):. PubMed ID: 25232921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].
    Kinderkrankenschwester; 2009 Nov; 28(11):463-5. PubMed ID: 19953852
    [No Abstract]   [Full Text] [Related]  

  • 13. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
    Press R; Andersen O
    Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
    [No Abstract]   [Full Text] [Related]  

  • 15. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
    Enserink M
    Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
    [No Abstract]   [Full Text] [Related]  

  • 16. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of influenza vaccines in pregnant women.
    Munoz FM
    Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S33-7. PubMed ID: 22920057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
    Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
    Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits to mother and child of influenza vaccination during pregnancy.
    Omer SB; Bednarczyk R; Madhi SA; Klugman KP
    Hum Vaccin Immunother; 2012 Jan; 8(1):130-7. PubMed ID: 22251998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.